Acute Lymphoblastic Leukemia (ALL)
69
14
20
27
Key Insights
Highlights
Success Rate
79% trial completion
Published Results
16 trials with published results (23%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
10.1%
7 terminated out of 69 trials
79.4%
-7.1% vs benchmark
9%
6 trials in Phase 3/4
59%
16 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (69)
Bio-CAR-T BS Study
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
Role of T Lymphocytes in Hypersensitivity Reactions to Asparaginase in Patients Treated for Acute Lymphoblastic Leukemia.
TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
A Study to Evaluate the Tolerability, Safety, and Efficacy of an Anti-CD19 CAR-T Product in Patients With B-cell Lymphoproliferative Disorders
Reduce Sedentary Time in Acute Lymphoblastic Leukemia
Expanded Access to Venetoclax
Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
CAYA Cancer Retrospective Cohort Study
Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
ALL Backbone in AYAs
Cord Blood Transplant in Adults With Blood Cancers
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol